Armata Pharmaceuticals, Inc.
ARMP · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 14.2% | -17.8% | 23.1% | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | -565.4% | 78.5% | -535.7% | -347.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -794.6% | -1,445.1% | -654.6% | -490% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -365.6% | -1,524.5% | -670.2% | -517.5% |
| EPS Diluted | -0.523 | -1.91 | -1.08 | -0.96 |
| % Growth | 72.6% | -76.9% | -12.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |